NASDAQ: RKLB Rocket Lab Corp 8-K

Rocket Lab launches up to $3B at-the-market equity program with forward sale options

Filed May 20, 2026 · Period ending May 20, 2026 · ~1 min read

Key Changes

high

Rocket Lab can now sell up to $3 billion of common stock over time through 16 sales agents, representing significant potential dilution to existing shareholders. Sales can occur directly or through complex forward arrangements.

Item 1.01 view on EDGAR →
high

Forward sale structures allow banks to borrow and sell shares immediately while Rocket Lab receives no cash upfront. The company only gets proceeds later when physically settling by delivering shares, deferring both cash receipt and dilution.

Item 1.01: Initially Priced Forward view on EDGAR →
medium

Collared forward transactions with Goldman Sachs or Morgan Stanley provide downside protection through floor pricing and allow partial prepayments, but cap the company's upside participation in stock price gains.

Item 1.01: Collared Forward view on EDGAR →
low

All sales carry commissions up to 2% of sale price. The offering uses an existing shelf registration from March 2025, confirming proper legal framework was already in place.

Item 1.01: Commission structure view on EDGAR →

Summary

Rocket Lab has established a massive up to $3 billion at-the-market equity program, giving the company unprecedented flexibility to raise capital by selling shares into the market over time. Unlike a traditional stock offering, this program allows Rocket Lab to sell shares gradually at prevailing market prices through 16 major investment banks.

The company can also use sophisticated forward sale arrangements where banks borrow and sell shares immediately to hedge their exposure, but Rocket Lab doesn't receive cash or issue shares until later settlement dates. For retail investors, this represents substantial potential dilution—up to $3 billion could translate to hundreds of millions of new shares depending on the stock price when sales occur.

The forward structures add complexity: they allow Rocket Lab to lock in approximate pricing and defer dilution, but also mean share sales may be happening in the market without immediate disclosure of how much cash the company is actually receiving. The collared forwards provide some downside protection but cap upside. Watch for quarterly disclosures of how much of this program Rocket Lab actually uses. Heavy utilization would signal either aggressive growth investment or potential cash needs, while light usage might indicate the program is primarily a precautionary measure. The company's cash burn rate and contract wins in upcoming quarters will reveal whether this capital raise funds expansion or addresses liquidity concerns.

Section-by-Section Diff

Event · Item 8.01 — Other Events

~3,200 words

Rocket Lab entered into a up to $3B at-the-market equity offering program with multiple sales agents and forward sale arrangements.

5 Added

Added $3B equity distribution agreement high

Added in current filing · verify on EDGAR →

On May 20, 2026, Rocket Lab Corporation (the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”) with BofA Securities, Inc., BTIG, LLC, Cantor Fitzgerald & Co., Citizens JMP Securities, LLC, Craig-Hallum Capital Group LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, Needham & Company, LLC, Nomura Securities International, Inc. (acting through BTIG, LLC as agent), Robert W. Baird & Co. Incorporated, Roth Capital Partners, LLC, Stifel, Nicolaus & Company, Incorporated, TD Securities (USA) LLC and Wells Fargo Securities, LLC, as sales agents (in such capacity, each, a “Sales Agent” and, collectively, the “Sales Agents”), the Forward Sellers (as defined below) and the Forward Purchasers (as defined below). Under the Equity Distribution Agreement, the Company may offer and sell, from time to time, shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) (the “Shares”), through or to the Sales Agents, acting as the Company’s agents or principal, having an aggregate offering price of up to $3,000,000,000 or by the Forward Sellers, acting as sales agents for the relevant Forward Purchasers.

Rocket Lab established an at-the-market equity offering program allowing it to sell up to $3 billion of common stock over time through 16 sales agents. The company can sell shares directly or through complex forward sale arrangements where borrowed shares are sold first and the company receives proceeds later upon settlement. This provides significant capital-raising flexibility but will dilute existing shareholders.

Added Initially Priced Forward Transactions high

Added in current filing · verify on EDGAR →

In a Forward Transaction under one form of forward sale agreement, referred to as an “Initially Priced Forward Transaction,” the Company may enter into one or more Initially Priced Forward Transactions with a Forward Purchaser, pursuant to which the Company will receive the forward sale price under the forward sale agreement at the settlement of the Initially Priced Forward Transaction, subject to the price adjustment and other provisions of the applicable forward sale agreement. The initial forward sale price per share under each Initially Priced Forward Transaction will be equal to the product of (1) an amount equal to one minus the applicable forward hedge selling commission rate and (2) the adjusted volume weighted average hedge price per share at which the borrowed shares of Common Stock were sold pursuant to the Equity Distribution Agreement by the relevant Forward Seller to hedge the relevant Forward Purchaser’s exposure under such Initially Priced Forward Transaction. The Company will not initially receive any proceeds from the sale of borrowed shares by the relevant Forward Seller.

The company can enter forward sale agreements where banks borrow and sell shares immediately to hedge their exposure, but Rocket Lab receives no cash upfront. The company only receives proceeds later when it physically settles by delivering shares, with the price based on where the borrowed shares were sold minus commissions up to 2%. This structure allows the company to lock in approximate pricing while deferring both cash receipt and share dilution.

Added Collared Forward Transactions medium

Added in current filing · verify on EDGAR →

In a separate Forward Transaction under another form of forward sale agreement, referred to herein as a “Collared Forward Transaction,” the Company may enter into one or more collared forward transactions (“Collared Forward Sale Agreements”) with Goldman Sachs & Co. LLC or Morgan Stanley & Co. LLC, each acting in its capacity as a Forward Purchaser (the “Collared Forward Purchaser”), pursuant to which the Company will agree to sell to the relevant Collared Forward Purchaser up to the number of shares of Common Stock specified in the Collared Forward Sale Agreement (subject to adjustment as set forth therein) and the relevant Collared Forward Purchaser will borrow from third-party stock lenders and sell the maximum number of shares of Common Stock deliverable pursuant to the Collared Forward Transaction (the “Hedging Shares”) through the related Sales Agent, acting as a Forward Seller (the “Collared Forward Seller”) over a period of time to be agreed between the Company and the relevant Collared Forward Purchaser (an “Initial Hedging Period”), all subject to the terms of the Equity Distribution Agreement and the Collared Forward Sale Agreement.

Rocket Lab can enter collared forward transactions with Goldman Sachs or Morgan Stanley where the settlement price is capped and floored based on the weighted average price at which borrowed shares are sold. The company can receive prepayments equal to the present value of the floor price (minus commissions) before settlement, with additional proceeds at maturity if the stock price exceeds the floor. This structure provides downside protection and upfront partial liquidity while capping upside participation.

Show 2 minor / wording changes

Added Commission structure low

Added in current filing · verify on EDGAR →

The Company will pay each of the Sales Agents a commission not to exceed 2.00% of the sales price per share of shares sold through it as agent under the Equity Distribution Agreement. The net proceeds that the Company will receive from such sales will be the gross proceeds from such sales less the commissions and any other costs that the Company may incur in issuing the shares. In connection with each Initially Priced Forward Transaction, the relevant Forward Seller will receive a commission of up to 2.00% of the volume weighted average of the sales prices of all borrowed shares of Common Stock sold during the applicable hedge period by it as a Forward Seller, reflected in a reduced initial forward sale price payable by the relevant Forward Purchaser under its forward sale agreement.

All sales under the program carry commissions up to 2% of the sale price, whether direct sales or forward transactions. For forward transactions, the commission reduces the forward sale price the company ultimately receives rather than being paid separately. This is a standard cost structure for at-the-market equity programs.

Added Shelf registration basis low

Added in current filing · verify on EDGAR →

The offer and sale of the Shares will be made pursuant to a shelf registration statement on Form S-3, which Rocket Lab USA, Inc., the Company’s predecessor, filed with the Securities and Exchange Commission (the “SEC”) on March 11, 2025, which automatically became effective upon filing, as amended by Post-Effective Amendment No. 1 to such registration statement, filed by the Company with the SEC on May 27, 2025, and a related prospectus supplement, which the Company filed with the SEC on May 20, 2026.

The equity offering is being conducted under an existing shelf registration statement filed in March 2025 and amended in May 2025, with a prospectus supplement filed May 20, 2026. This confirms the offering is properly registered and the company had previously established the legal framework for this capital raise.

Event · Item 9.01 — Financial Statements and Exhibits

~200 words

Rocket Lab entered an equity distribution agreement with 17 underwriters to enable at-the-market stock offerings.

1 Added

Added Equity Distribution Agreement high

Added in current filing · verify on EDGAR →

Equity Distribution Agreement, dated as of May 20, 2026, by and among Rocket Lab Corporation, BofA Securities, Inc., BTIG, LLC, Cantor Fitzgerald & Co., Citizens JMP Securities, LLC, Craig-Hallum Capital Group LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, Needham & Company, LLC, Nomura Securities International, Inc., Robert W. Baird & Co. Incorporated, Roth Capital Partners, LLC, and Stifel, Nicolaus & Company, Incorporated, TD Securities (USA) LLC and Wells Fargo Securities, LLC, Bank of America, N.A., Deutsche Bank AG, London Branch, Nomura Global Financial Products, Inc., The Toronto-Dominion Bank and Wells Fargo Bank, National Association.

Rocket Lab has established an at-the-market equity offering program with 17 financial institutions serving as sales agents and forward sellers. This arrangement allows the company to sell shares into the market over time at prevailing prices, providing flexible access to capital without a traditional underwritten offering. The agreement involves major investment banks including Goldman Sachs, Morgan Stanley, BofA Securities, and Deutsche Bank.